GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (TSE:4536) » Definitions » Cyclically Adjusted PB Ratio

Santen Pharmaceutical Co (TSE:4536) Cyclically Adjusted PB Ratio : 2.18 (As of Jun. 06, 2024)


View and export this data going back to 1964. Start your Free Trial

What is Santen Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Santen Pharmaceutical Co's current share price is 円1641.00. Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円752.78. Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 2.18.

The historical rank and industry rank for Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4536' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.43   Med: 2.87   Max: 4.36
Current: 2.16

During the past years, Santen Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 4.36. The lowest was 1.43. And the median was 2.87.

TSE:4536's Cyclically Adjusted PB Ratio is ranked worse than
54.37% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs TSE:4536: 2.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was 円842.642. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円752.78 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.39 2.59 1.92 1.62 2.02

Santen Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 1.72 1.88 1.89 2.02

Competitive Comparison of Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1641.00/752.78
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Santen Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=842.642/107.2000*107.2000
=842.642

Current CPI (Mar. 2024) = 107.2000.

Santen Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 437.769 98.000 478.866
201409 455.637 98.500 495.881
201412 473.302 97.900 518.263
201503 512.477 97.900 561.160
201506 523.343 98.400 570.146
201509 606.306 98.500 659.858
201512 625.107 98.100 683.093
201603 627.785 97.900 687.421
201606 618.666 98.100 676.055
201609 615.758 98.000 673.564
201612 623.452 98.400 679.208
201703 628.093 98.100 686.356
201706 639.625 98.500 696.120
201709 664.681 98.800 721.192
201712 687.468 99.400 741.414
201803 702.544 99.200 759.201
201806 706.743 99.200 763.738
201809 744.087 99.900 798.460
201812 729.859 99.700 784.763
201903 728.855 99.700 783.684
201906 722.156 99.800 775.703
201909 735.648 100.100 787.827
201912 757.132 100.500 807.607
202003 758.262 100.300 810.426
202006 766.356 99.900 822.356
202009 791.054 99.900 848.859
202012 788.861 99.300 851.620
202103 775.804 99.900 832.494
202106 779.358 99.500 839.670
202109 799.378 100.100 856.077
202112 803.798 100.100 860.811
202203 843.149 101.100 894.021
202206 873.755 101.800 920.103
202209 799.350 103.100 831.138
202212 784.708 104.100 808.076
202303 782.815 104.400 803.810
202306 813.491 105.200 828.957
202309 837.046 106.200 844.928
202312 822.494 106.800 825.575
202403 842.642 107.200 842.642

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Santen Pharmaceutical Co  (TSE:4536) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (TSE:4536) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (TSE:4536) Headlines

No Headlines